Pfizer Says Its Vaccine Is Highly Effective in 5- to 11-Year-Olds

The companies reported that a lower dose of the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial.

from NYT > U.S. > Politics https://ift.tt/3b09LsW